drugset / Trial / NCT00003684

Theophylline in Treating Cancer Patients With Shortness of Breath

NCT00003684

Phase 3 Completed 3 enrolled NCIC Clinical Trials Group
RandomizedParallel-groupTriple-blindSupportive care

Summary

RATIONALE: Theophylline may help to relieve shortness of breath in patients who have cancer. It is not yet known whether theophylline is more effective than no further treatment for shortness of breath. PURPOSE: Randomized phase III trial to determine the effectiveness of theophylline in treating shortness of breath in patients who have cancer.

Timeline

Start
1998-03-24
Primary completion
2008-12-15
Completion
2008-12-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Theophylline Small molecule Oral